BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Alex Ide as the company’s Executive Vice President (EVP) of Sales for the UK. In this pivotal role, Alex will be overseeing the customer-facing work underpinning the company’s commercial success through acquisition of new clients in a major market pioneering […]
Delivers 2-4x increase in AAV titers across many serotypes, cell lines, growth media, and transfection reagents Significantly reduces production costs and doubles the doses that can be produced in a single bioreactor run MADISON, Wis. — Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy […]
License allows Transomic Technologies to develop and commercialize products using CRISPR/Cas9. Dublin, Ireland and Huntsville, AL, USA, August 3, 2023: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Transomic Technologies (‘Transomic,’). This is a non-exclusive licensing agreement granting Transomic access to the foundational ERS CRISPR/Cas9 patent portfolio. Dr. Emmanuelle Charpentier, […]
PacBio will Combine Apton’s Proprietary Sequencing Technology With its Highly Accurate Sequencing by Binding Chemistry to Develop a High-Throughput Sequencer Designed to Deliver Billions of Reads per Flow Cell MENLO PARK, Calif. — PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced that it has entered into an agreement to acquire Apton Biosystems, Inc (Apton), […]
The Onso Platform Delivers Extraordinary Accuracy Which Creates New Possibilities for Research and Translational Sequencing Applications MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that customer shipments of Onso short-read sequencing instruments will commence today. As previously announced, the Onso system is designed to provide extraordinary accuracy through its novel sequencing […]
Complete collaborative environment with intuitive interface addresses common analysis challenges to help accelerate transition from scientific discovery to data-driven precision medicine MOUNTAIN VIEW, Calif., and LUGANO, Switzerland — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced a collaboration with BigOmics Analytics, a Swiss biomedical data […]
BEIJING — Recently, Atantares announced the completion of Pre-A and Pre-A+ financing all around RMB100 million. The Pre-A round is led by Asia Green Fund, followed by Fosun Health Capital and existing investors Frees Fund, Qiming Venture Partners, Next Capital, and NeuX Capital; Pre-A+ is exclusively invested by Alibaba Health. The fund will mainly go towards the R&D of […]
Next Gen RNA fragmentomics-based diagnostics SANTA CRUZ, CALIFORNIA, UNITED STATES — RealSeq Biosciences, Inc., a company developing RNA fragmentomics as real-time diagnostics for disease, today announced the close of its oversubscribed seed round. The investment allows RealSeq to deploy the RiboMarkerTM molecular diagnostics platform toward its first indication, Valley Fever, a fungal disease related to […]
William “Trey” Martin, III assumes the role of Maravai’s CEO Carl Hull to continue to serve as Executive Chairman SAN DIEGO, Calif. — Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that William “Trey” Martin, III has assumed the […]
HERCULES, Calif., & VENLO, the Netherlands — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
